ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ -- Thousands of health and technology leaders will gather to share critical health technology…
Leverage Gen AI and agentic AI to deliver new fan experiences including enhanced and personalized match analysis and creative content…
The Smart Industry leader supports major companies in the aviation, aerospace and defense industry with digital transformation and invites visitors…
Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today…
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…
Live demonstrations will highlight how computational intelligence is shaping the future of flight TROY, Mich., June 2, 2025 /PRNewswire/ -- Altair,…
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing…
Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic…